Abstract

Preparation and Characterization of a Compounded Aqueous Human Insulin Suspension

Author(s): Al-Achi Antoine, Parekh Bhavita

Issue: Nov/Dec 2004 - Endotoxin

Page(s): 492-495

Download in electronic PDF format for $75
  • Preparation and Characterization of a Compounded Aqueous Human Insulin Suspension Page 1
  • Preparation and Characterization of a Compounded Aqueous Human Insulin Suspension Page 2
  • Preparation and Characterization of a Compounded Aqueous Human Insulin Suspension Page 3
  • Preparation and Characterization of a Compounded Aqueous Human Insulin Suspension Page 4

Abstract

Human insulin, used in the management of diabetes, is commercially available in the form of solutions or suspensions for injection. This study investigated the preparation and characterization of an oral suspension for insulin. The suspension was prepared by adding human insulin to aqueous soy extract and adjusting the pH of the preparation to 4.0. The mean diameters of insulin particles at this pH were measured to be 29.93 and 28.30 micrometers for voume-surface mean and volume-number mean, respectively. After 24 hours of the suspension standing at room temperature, the sedimentation volume reached a constant value of 0.22. The suspension exchibited shear-thinning rheological properties, since its viscosity decreased when the rate of shear was increased. The formulation was stable for about 18 days when stored in the refrigerator (4 degrees C). Compared to a simple solution of insulin stored at a similar acidic pH reported in the literature, the stability of insulin in the suspension has improved over 2000-fold.

Related Keywords

  • human insulin
  • diabetes
  • oral suspension
  • aqueous soy extract
  • pH
  • proteolytic enzyme inhibitor
  • inhibition of proteolytic enzymes

Related Categories

  • DIABETES
  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2004
Pg. 492-495
Preparation and Characterization of a Compounded Aqueous Human Insulin Suspension
Author(s): Al-Achi Antoine, Parekh Bhavita
May/Jun 2003
Pg. 170-174
Five Compounds for Treating Diabetes-Related Conditions
Author(s): Meece Jerry
Mar/Apr 2000
Pg. 88-90
Complications of Diabetes
Author(s): Key David M
Mar/Apr 2000
Pg. 103-104
Diabetes Book Reviews
Author(s): Reed-Kane Dana
Jul/Aug 2015
Pg. 289-293
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity
Author(s): Biundo Bruce, Gogola Margaret
Mar/Apr 2011
Pg. 124-128
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Author(s): Corsini Lindsay, Williams LaVonn A
May/Jun 2018
Pg. 196-202
Case Report of a Human Papillomavirus Infection Treated with Green Tea Extract and Curcumin Vaginal Compounded Medications
Author(s): Agbi Kelechi E, Hover Sara, Carvalho Maria
Mar/Apr 1997
Pg. 128-131
Stability of Allopurinol Suspension Compounded from Tablets
Author(s): Alexander Kenneth S, Davar Nipun, Parker Gordon A
Jan/Feb 2017
Pg. 47-56
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Author(s): Akers Michael J
Nov/Dec 2021
Pg. 468-472
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin
Author(s): Riepl Mike
Jul/Aug 2014
Pg. 332-340
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream
Author(s): Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
Nov/Dec 2018
Pg. 494
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2016
Pg. 333-337
Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations
Author(s): Lupatini Nogueira Rodrigo José, Danopoulos Panagiota, Swikidisa Rosita, Alves Pinheiro Vanessa
Mar/Apr 2016
Pg. 167-174
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Author(s): Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA
May/Jun 2006
Pg. 221
Enalapril Maleate 1-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2017
Pg. 160-163
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions
Author(s): Kabiche Djamila, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
Sep/Oct 2023
Pg. 420
Nitazoxanide 20-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2013
Pg. 508-511
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles
Author(s): McPherson Timothy B, Neumann William L, Kolling William M
Jan/Feb 2023
Pg. 58-59
Suspension Solution, Sugar Free
Author(s): Allen Loyd V Jr
Mar/Apr 2014
Pg. 169-174
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets
Author(s): Zaid Abdel Naser, Assali Mohyeddin, Qaddomi Aiman, Ghanem Mashhour, Zaaror Yara Abu